In the pre-treatment phase, all patients undergo extensive diagnostic testing to capture the most complete image of the immune system.
The interface is the relationship between allergic foods and an individual’s immune system. During this phase, we identify biosimilar proteins to retrain the immune system and safely build tolerance one protein at a time. Biosimilar proteins are proteins similar to those in a patient’s allergens.
Once a patient’s immune system is accustomed to biosimilar food proteins, they can safely begin to “challenge” their allergens in increasing amounts until complete Tolerance is achieved.